SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 1.000+2.1%11:29 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bucky Katt who wrote (8783)3/27/1998 10:14:00 AM
From: Bob Jagow  Read Replies (3) of 14328
 
The story said Murex, Bill.
Today's WSJI has a funny follow up--after saying
-----
the revision in public health policy is likely to prove a boon to International Murex Technologies Corp.'s Murex Diagnostics Inc. unit [which] currently has the only rapid HIV test that is approved by the Food and Drug Administration -- the SUDS HIV-1 test. Murex officials said they had been anticipating the CDC report and that they thought it would be positive for the company [because] the rapid test currently accounts for about 21% of U.S. sales.
------
, they point out that "International Murex Technologies, Toronto, fell 6.25 cents to $19.5625 in Nasdaq Stock Market trading Thursday."
Guess they forgot that ABT tendered for them on 3/16.
MUREX is up that 16th this AM.

Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext